Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment

被引：3
|
作者：
Girardin, Francois R. [1 ]
Cohen, Karen [2 ]
Schwenkglenks, Matthias [3 ,4 ]
Durand-Zaleski, Isabelle [5 ]
机构：
[1] Univ Lausanne, Lausanne Univ Hosp, Fac Med, Dept Lab Med & Pathol,Div Clin Pharmacol, Lausanne, Switzerland
[2] Univ Cape Town, Dept Med, Div Clin Pharmacol, Cape Town, South Africa
[3] Univ Basel, Inst Pharmaceut Med ECPM, Basel, Switzerland
[4] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland
[5] Univ Paris Est Creteil, Hotel Dieu, AP HP, URCEco, Paris, France
来源：
FRONTIERS IN PHARMACOLOGY | 2023年 / 14卷
关键词：
pharmacoeconomics; health technology assessment (HTA); patient related outcome; disinvestment choices; cost-effectiveness; SURROGATE END-POINTS;
D O I：
10.3389/fphar.2023.1210002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Social Life Cycle Assessment as a resource for Responsible Research and Innovation
    Thorstensen, Erik
    Forsberg, Ellen-Marie
    JOURNAL OF RESPONSIBLE INNOVATION, 2016, 3 (01) : 50 - 72
  • [22] Health technology assessment: a sociological commentary on reflexive innovation
    Webster, A
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2004, 20 (01) : 61 - 66
  • [23] Health technology assessment and innovation: here to help or hinder?
    Mundy, Linda
    Forrest, Ben
    Huang, Li-Ying
    Maddern, Guy
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2024, 40 (01)
  • [24] Medical innovation and the critical role of health technology assessment
    Perry, S
    Thamer, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (19): : 1869 - 1872
  • [25] Assessment of impacts of green technology and innovation on sustainable mineral resource production
    Wang, Wei
    Liu, Dongsheng
    Chen, Lifeng
    Song, Meizhe
    Xu, Jiaqi
    RESOURCES POLICY, 2024, 90
  • [26] Exploring the digital era: Has digital technology innovation reshaped investment efficiency in Chinese enterprises?
    Lai, Xiaobing
    Quan, Lei
    Guo, Chong
    Gao, Xing
    RESEARCH IN INTERNATIONAL BUSINESS AND FINANCE, 2025, 75
  • [27] How has the future investment program stimulated research and innovation in health?
    Bordet, Regis
    Dantonel, Jean-Christophe
    Vacaresse, Eric
    Le Jeunne, Claire
    Benhabiles, Nora
    Beretz, Alain
    Boitard, Christian
    Debette, Stephanie
    Duluc, Gilles
    Froguel, Philippe
    Garbil, Benedicte
    Lyonnet, Stanislas
    Mahfoudi, Abderrahim
    Marquet, Pierre
    Mouthon, Franck
    Rascol, Olivier
    Richard, Vincent
    Simon, Emmanuelle
    Varoqueaux, Nathalie
    Watier, Herve
    Zins, Marie
    THERAPIE, 2022, 77 (01): : 19 - 24
  • [28] Investment Value Assessment Model of the National Critical Technology Based on Independent Innovation
    Guo, Weidong
    PROCEEDINGS OF THE 2012 24TH CHINESE CONTROL AND DECISION CONFERENCE (CCDC), 2012, : 793 - 798
  • [29] Pharmacoeconomics and Outcomes Research - What is it and how is it being applied in the South African health care system?
    McGee, Shelley
    SA PHARMACEUTICAL JOURNAL, 2010, 77 (05) : 62 - 63
  • [30] Research on Investment value model of the National Critical Technology based on independent innovation
    Guo, Weidong
    2008 CHINESE CONTROL AND DECISION CONFERENCE, VOLS 1-11, 2008, : 2082 - 2087
12345